Aqsens Health (Finland) and Equity Health Insurance (Ghana) have signed a Memorandum of Understanding (MOU) to accelerate market entry for AQ Malaria and other tests to be developed for developing economies.
According to management, the two companies are also working on a business plan to incorporate a local subsidiary for Aqsens in Ghana, which will focus on Ghanaian and West African markets.
Aqsens Health’s CEO, Timo Teimonen, COO Riikka Erkkilä, and Aqsens’ founder and board member Professor Pekka Hänninen visited Ghana, met with key stakeholders, and signed an MOU with Equity Health Insurance CEO and President Elton Afari.
Equity Health Insurance is a privately owned health insurance company in Ghana that offers health insurance protection with a novel model. Equity combines insurance protection with diagnostics, pharmacy services, and respective treatment through its growing Medcare Plus clinic chain in Ghana.
Through this partnership, Aqsens Health and Equity Health Insurance aim to develop a larger portfolio of tests using E-TRF and biosensors. The two companies hope to create a positive socio-economic impact in Ghana by utilising Aqsens’ service model in the Ghanaian healthcare system.
Aqsens Health and Equity Health Insurance share a vision of enabling better and more equal access to healthcare across Ghana by developing and providing affordable screening services for diseases that affect both individuals and society as a whole.
